Testing inhomogeneous solvation theory in structure-based ligand discovery

被引:56
|
作者
Balius, Trent E. [1 ]
Fischer, Marcus [1 ,7 ,8 ]
Stein, Reed M. [2 ]
Adler, Thomas B. [1 ]
Nguyen, Crystal N. [3 ]
Cruz, Anthony [4 ,5 ]
Gilson, Michael K. [3 ]
Kurtzman, Tom [4 ,5 ,6 ]
Shoichet, Brian K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94158 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[4] Lehman Coll, Dept Chem, Bronx, NY 10468 USA
[5] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA
[6] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA
[7] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
water; inhomogeneous solvation theory; ligand discovery; structure-based drug design; docking; MOLECULAR-DYNAMICS; FREE-ENERGIES; ACTIVE-SITE; WATER-MOLECULES; THERMODYNAMIC CONTRIBUTIONS; FLUID APPROACH; BINDING-SITE; SOLVENT; DOCKING; FLEXIBILITY;
D O I
10.1073/pnas.1703287114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Binding-site water is often displaced upon ligand recognition, but is commonly neglected in structure-based ligand discovery. Inhomogeneous solvation theory (IST) has become popular for treating this effect, but it has not been tested in controlled experiments at atomic resolution. To do so, we turned to a grid-based version of this method, GIST, readily implemented in molecular docking. Whereas the term only improves docking modestly in retrospective ligand enrichment, it could be added without disrupting performance. We thus turned to prospective docking of large libraries to investigate GIST's impact on ligand discovery, geometry, and water structure in a model cavity site well-suited to exploring these terms. Although top-ranked docked molecules with and without the GIST term often overlapped, many ligands were meaningfully prioritized or deprioritized; some of these were selected for testing. Experimentally, 13/14 molecules prioritized by GIST did bind, whereas none of the molecules that it deprioritized were observed to bind. Nine crystal complexeswere determined. In six, the ligand geometry corresponded to that predicted by GIST, for one of these the pose without the GIST term was wrong, and three crystallographic poses differed fromboth predictions. Notably, in one structure, an ordered water molecule with a high GIST displacement penalty was observed to stay in place. Inclusion of this water-displacement term can substantially improve the hit rates and ligand geometries from docking screens, although the magnitude of its effects can be small and its impact in drug binding sites merits further controlled studies.
引用
收藏
页码:E6839 / E6846
页数:8
相关论文
共 50 条
  • [41] Serial Crystallography for Structure-Based Drug Discovery
    Zhu, Lan
    Chen, Xiaoyu
    Abola, Enrique E.
    Jing, Liang
    Liu, Wei
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (11) : 830 - 839
  • [42] Virtual screening in structure-based drug discovery
    Barril, X
    Hubbard, RE
    Morley, SD
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2004, 4 (07) : 779 - 791
  • [43] Structure-based Design on Anticancer Drug Discovery
    Zhong, Haizhen Andrew
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (10) : 813 - 814
  • [44] STRUCTURE-BASED DISCOVERY OF INHIBITORS OF THYMIDYLATE SYNTHASE
    SHOICHET, BK
    STROUD, RM
    SANTI, DV
    KUNTZ, ID
    PERRY, KM
    SCIENCE, 1993, 259 (5100) : 1445 - 1450
  • [45] Discovery and Structure-Based Optimization of Adenain Inhibitors
    Mac Sweeney, Aengus
    Grosche, Philipp
    Ellis, David
    Combrink, Keith
    Erbel, Paul
    Hughes, Nicola
    Sirockin, Finton
    Melkko, Samu
    Bernardi, Anna
    Ramage, Paul
    Jarousse, Nadine
    Altmann, Eva
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 937 - 941
  • [46] Antibacterial drug discovery and structure-based design
    Barker, John J.
    DRUG DISCOVERY TODAY, 2006, 11 (9-10) : 391 - 404
  • [47] Structure-Based Discovery of Novel Glycinergic Modulators
    Wells, Marta M.
    Reinert, Nathan
    Tang, Pei
    Xu, Yan
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 556A - 556A
  • [48] Structure-based screening for discovery of sweet compounds
    Ben Shoshan-Galeczki, Yaron
    Niv, Masha Y.
    FOOD CHEMISTRY, 2020, 315
  • [49] Structure-based discovery of CFTR potentiators and inhibitors
    Liu, Fangyu
    Kaplan, Anat Levit
    Levring, Jesper
    Einsiedel, Jurgen
    Tiedt, Stephanie
    Distler, Katharina
    Omattage, Natalie S.
    Kondratov, Ivan S.
    Moroz, Yurii S.
    Pietz, Harlan L.
    Irwin, John J.
    Gmeiner, Peter
    Shoichet, Brian K.
    Chen, Jue
    CELL, 2024, 187 (14) : 3712 - 3725.e34
  • [50] Structure-Based Drug Discovery for Tropical Diseases
    Guido, Rafael V. C.
    Oliva, Glaucius
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (09) : 824 - 843